Concomitant botanical medicine use among patients participating in commercial prostate cancer trials.
- DOI
- 10.1016/j.ctim.2020.102549
- Published
- 2020 Nov
- Container
- Complementary therapies in medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctim.2020.102549,
title = {Concomitant botanical medicine use among patients participating in commercial prostate cancer trials.},
author = {Roydhouse JK and Menapace LA and Xia H and Song P and Berman T and Agarwal R and Suzman DL and Wright K and Beaver JA and Kluetz PG},
year = {2020},
journal = {Complementary therapies in medicine},
doi = {10.1016/j.ctim.2020.102549},
url = {https://doi.org/10.1016/j.ctim.2020.102549}
}RIS
TY - JOUR TI - Concomitant botanical medicine use among patients participating in commercial prostate cancer trials. AU - Roydhouse JK AU - Menapace LA AU - Xia H AU - Song P AU - Berman T AU - Agarwal R AU - Suzman DL AU - Wright K AU - Beaver JA AU - Kluetz PG PY - 2020 JO - Complementary therapies in medicine DO - 10.1016/j.ctim.2020.102549 UR - https://doi.org/10.1016/j.ctim.2020.102549 ER -
APA
JK, R., LA, M., H, X., P, S., T, B., R, A., DL, S., K, W., JA, B., & PG, K. (2020). Concomitant botanical medicine use among patients participating in commercial prostate cancer trials.. Complementary therapies in medicine. https://doi.org/10.1016/j.ctim.2020.102549
Source records
- pubmed · retrieved 2026-09-25T13:10:19.266Z